ABOUT THE CONGRESS
The Global Endocrine Systems & Metabolic Health Congress 2027 (GESMHC 2027) is an international academic forum dedicated to advancing integrated approaches across endocrinology, metabolic disorders, and systemic health regulation.
Endocrine diseases — including diabetes, thyroid disorders, obesity, adrenal dysfunction, reproductive hormonal imbalance, and cardiometabolic syndromes — represent a growing global burden. Yet care delivery, prevention strategies, research translation, and policy coordination remain structurally fragmented.
GESMHC 2027 positions endocrine health within a broader systems-oriented framework that aligns:
• Clinical endocrinology and specialty care pathways
• Metabolic disease prevention and population strategy
• Translational research and implementation science
• Digital diagnostics and AI-enabled decision support
• Workforce sustainability and interdisciplinary collaboration
• Governance, financing, and health system integration
Organized under the WebiConX Global Congress Platform, the congress fosters evidence-driven dialogue connecting clinicians, researchers, policy leaders, and institutional stakeholders working toward scalable endocrine care models.
For detailed thematic domains, refer to the Scientific Program Architecture.
CONGRESS GOVERNANCE
The Global Endocrine Systems & Metabolic Health Congress 2027 (GESMHC 2027) is governed through a comprehensive academic framework that ensures scientific quality, ethical standards, and international collaboration throughout the congress. Organized by WebiConX, the congress is guided by experienced clinicians, researchers, educators, and healthcare leaders who collectively oversee the scientific direction, program development, and academic integrity of the event. This governance model is designed to foster meaningful interdisciplinary dialogue while maintaining the highest standards of scholarly excellence.
The governance structure comprises the Organizing Committee, Scientific Committee, International Advisory Board, and Abstract Review Panel, each playing a distinct role in planning and delivering a high-quality scientific program. From defining thematic priorities and reviewing abstracts to selecting speakers and ensuring balanced representation across disciplines, every stage of the congress is managed through a transparent and evidence-based process. This collaborative approach promotes innovation, encourages global participation, and strengthens the translation of research into effective clinical practice, healthcare policy, and systems-based solutions for endocrine and metabolic health.
GESMHC 2027 is committed to creating an inclusive and globally connected scientific platform where experts from academia, healthcare, research institutions, government, and industry can exchange knowledge, build partnerships, and address the evolving challenges of endocrine and metabolic disorders. By emphasizing scientific rigor, multidisciplinary collaboration, and real-world impact, the congress seeks to advance sustainable healthcare systems and improve patient outcomes worldwide.
SCIENTIFIC PROGRAM ARCHITECTURE
The scientific program is structured across six Core Thematic Tracks, each designed to bridge clinical excellence with systemic integration.
Track 1: Clinical Endocrinology & Hormonal Disorders
Description:
Focuses on diagnostic precision, therapeutic advancements, and multidisciplinary management of endocrine conditions.
Subtracks:
• Diabetes & Glycemic Management Innovations
• Thyroid & Parathyroid Disorders
• Adrenal & Pituitary Pathophysiology
• Reproductive & Gonadal Endocrinology
• Pediatric & Developmental Endocrine Disorders
Track 2: Metabolic Health & Cardiometabolic Integration
Description:
Explores obesity, lipid metabolism, insulin resistance, and the intersection between endocrine and cardiovascular systems.
Subtracks:
• Obesity Medicine & Weight Regulation
• Lipid Disorders & Metabolic Syndrome
• Insulin Resistance & Pre-Diabetes Prevention
• Endocrine–Cardiovascular Interactions
• Nutrition, Lifestyle & Metabolic Modulation
Track 3: Translational Endocrine Research & Precision Medicine
Description:
Examines molecular pathways, biomarker discovery, genomics, and translational pipelines in endocrine science.
Subtracks:
• Endocrine Genetics & Epigenetics
• Biomarkers & Diagnostic Innovation
• Precision Medicine in Hormonal Disorders
• Clinical Trials & Therapeutic Development
• Research-to-Practice Implementation Models
Track 4: Endocrine Systems, Policy & Population Health
Description:
Addresses endocrine disease burden at systems and population levels.
Subtracks:
• Diabetes Prevention Programs & Public Health Strategy
• Global Endocrine Disease Epidemiology
• Health Financing & Access Models
• Regulatory & Governance Frameworks
• Health Systems Integration & Care Coordination
Track 5: Digital Endocrinology & AI in Metabolic Care
Description:
Explores digital diagnostics, wearable technologies, AI-driven risk stratification, and data governance.
Subtracks:
• Continuous Glucose Monitoring & Smart Devices
• AI-Based Risk Prediction Models
• Tele-Endocrinology & Remote Care
• Digital Therapeutics & Behavioral Platforms
• Data Governance & Ethical Innovation
Track 6: Workforce, Education & Clinical Leadership
Description:
Focuses on training, interdisciplinary collaboration, and endocrine workforce sustainability.
Subtracks:
• Endocrine Education & Curriculum Reform
• Interdisciplinary Care Teams
• Workforce Distribution & Access Equity
• Leadership in Specialty Care Systems
• Burnout Prevention & Professional Sustainability
For confirmed faculty and leadership, visit the Speakers page.
Confirmed contributors and domain experts can be explored within the Speakers section.
PARTICIPATION FRAMEWORK
GESMHC 2027 supports structured participation aligned with academic integrity and governance standards.
Participation categories include:
• Presenting Authors
• Panel Contributors & Discussants
• Delegates
• Emerging Scholars
• Institutional & Industry Participants
• Scientific Review Committee & Advisors
Oversight is provided by the Organizing & Scientific Committee, ensuring peer-review rigor and thematic coherence.
Registration details are available on the Registration page.
GLOBAL SECTOR OUTLOOK
Endocrine and metabolic disorders are among the fastest-growing contributors to global morbidity. Rising diabetes prevalence, obesity trends, aging populations, and lifestyle transitions are reshaping healthcare priorities worldwide.
Despite scientific progress, gaps remain in early detection, prevention infrastructure, digital adoption, financing alignment, and workforce capacity.
The next phase of advancement requires:
• Integrated endocrine care within primary health systems
• Prevention-centered metabolic strategies
• Digital-enabled monitoring and data integration
• Sustainable specialist workforce planning
• Evidence-informed governance and financing frameworks
GESMHC 2027 convenes cross-sector stakeholders to address these structural imperatives through coordinated academic exchange.
EMERGING SCHOLARS & EARLY CAREER RESEARCH TRACK
The Emerging Scholars & Early Career Research Track supports doctoral candidates, postdoctoral researchers, medical fellows, and early-career faculty contributing to endocrine and metabolic research.
Submissions are evaluated under identical peer-review standards applied across all thematic domains.
Eligibility
• Doctoral and MD/DM trainees
• Postdoctoral fellows
• Early-career faculty (≤5 years post-degree)
• Clinician-researchers engaged in structured investigation
Recognition & Academic Distinction
• Emerging Scholar Presentation Distinction
• Featured Session Placement
• Highlighted Program Listing
Value & Engagement
• International scholarly visibility
• Integration across core thematic tracks
• Mentored interdisciplinary dialogue
• Professional positioning within systems-based endocrine research
Researchers may review guidelines on the Abstract Submission page.